The franchising program is offered by MergersUK Limited, a UK Company with its registered office at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom.
MergersCorp M&A International provides strategic business advisory services, including preparing companies for growth and capital access. Through partnerships with licensed investment bankers, clients can access tailored capital-raising solutions.
U.S. Investment Banking Securities transactions are exclusively conducted by Spektrum Capital Advisors LLC, a Registered Representative of, and Securities Products offered through, BA Securities, LLC, a FINRA-registered broker-dealer. Check the background of investment professionals associated with this site on Broker Check.
This company for sale is a healthcare company based in Bangalore, India. The business is involved in the manufacturing and supply of medicines and nutritional supplements to people across the globe (Quality standards as specified by WHO-GMP and ISO certifications).
The business is fully equipped ISO 9001 and WHO GMP certified unit is catering to orders from countries like Central America, Nigeria, Bangladesh, Cambodia, Sri Lanka, Malaysia, Dominican Republic etc. The unit has over 50000 square feet of built up area dedicated to production of tablets, capsules and oral liquids.
Company produces Generic, Nutraceuticals and Herbal Medical Products.
Financial Performance Highlights (3 Years)
Revenue has seen a steady increase in the last 3 years but with a reduction in EBITDA. The reduction in EBITDA is due to increased ad spend for an online brand started 5 years ago. Any profit made by this D2C supplements brand is being put back into marketing of the brand which has led to a reduction in EBITDA of the overall company.
Products
438 manufacturing licenses under generic pharmaceuticals. Out of these, company currently holds 148 CoPP approvals which allow us to register our products for export in multiple ROW countries.
Overarching Competitive Advantage
High production capacity for a small scale manufacturing facility with cost advantage. Manufacturing unit located inside the city of Bangalore allows access to both skilled and unskilled labour.
This company for sale is a healthcare company based in Bangalore, India. The business is involved in the manufacturing and supply of medicines and nutritional supplements to people across the globe (Quality standards as specified by WHO-GMP and ISO certifications).
The business is fully equipped ISO 9001 and WHO GMP certified unit is catering to orders from countries like Central America, Nigeria, Bangladesh, Cambodia, Sri Lanka, Malaysia, Dominican Republic etc. The unit has over 50000 square feet of built up area dedicated to production of tablets, capsules and oral liquids.
Company produces Generic, Nutraceuticals and Herbal Medical Products.
Financial Performance Highlights (3 Years)
Revenue has seen a steady increase in the last 3 years but with a reduction in EBITDA. The reduction in EBITDA is due to increased ad spend for an online brand started 5 years ago. Any profit made by this D2C supplements brand is being put back into marketing of the brand which has led to a reduction in EBITDA of the overall company.
Products
438 manufacturing licenses under generic pharmaceuticals. Out of these, company currently holds 148 CoPP approvals which allow us to register our products for export in multiple ROW countries.
Overarching Competitive Advantage
High production capacity for a small scale manufacturing facility with cost advantage. Manufacturing unit located inside the city of Bangalore allows access to both skilled and unskilled labour.
Description
This company for sale is a healthcare company based in Bangalore, India. The business is involved in the manufacturing and supply of medicines and nutritional supplements to people across the globe (Quality standards as specified by WHO-GMP and ISO certifications).
The business is fully equipped ISO 9001 and WHO GMP certified unit is catering to orders from countries like Central America, Nigeria, Bangladesh, Cambodia, Sri Lanka, Malaysia, Dominican Republic etc. The unit has over 50000 square feet of built up area dedicated to production of tablets, capsules and oral liquids.
Company produces Generic, Nutraceuticals and Herbal Medical Products.
Financial Performance Highlights (3 Years)
Revenue has seen a steady increase in the last 3 years but with a reduction in EBITDA. The reduction in EBITDA is due to increased ad spend for an online brand started 5 years ago. Any profit made by this D2C supplements brand is being put back into marketing of the brand which has led to a reduction in EBITDA of the overall company.
Products
438 manufacturing licenses under generic pharmaceuticals. Out of these, company currently holds 148 CoPP approvals which allow us to register our products for export in multiple ROW countries.
Overarching Competitive Advantage
High production capacity for a small scale manufacturing facility with cost advantage. Manufacturing unit located inside the city of Bangalore allows access to both skilled and unskilled labour.
Basic Details
Target Price:
$12,000,000
Gross Revenue
$1,900,000
EBITDA
TBA
Business ID:
L#20210016
Country
India
City:
Bangalore
Detail
Similar Businesses
Published on February 19, 2021 at 3:01 pm. Updated on February 10, 2022 at 10:01 am
50-Year-Old Italian Automotive Manufacturing Business of Vehicle Bodies and Trailers
€12,500,000
Manufacturing
Historical Multinational Contract Manufacturing Business
$100,000,000
Manufacturing
40 Year Old Pharmaceutical Manufacturing Business
$40,000,000
Manufacturing, Pharma
Large-scale Food Production Business
$15,560,570
Manufacturing
Stock Market Broker House with 35,000+ clients
$5,000,000
Manufacturing
20-Year-Old Established Swiss Italian Eco-friendly Packaging Manufacturing Business
$7,500,000
Manufacturing
PREVIOUS PROPERTY
Houston Based Video Sharing Portal / High Potential
NEXT PROPERTY
UK (FCA) Matched Principal Brokers